Breaking News, Collaborations & Alliances

Recro and BioCorRx Expand Development and Manufacturing Relationship

Will support BICX104, an implantable naltrexone pellet for the treatment of opioid use disorder.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Recro Pharma, a contract development and manufacturing organization (CDMO) dedicated to solving complex small molecule formulation and manufacturing challenges, and BioCorRx, a developer and provider of advanced solutions in the treatment of substance use disorders, have expanded the companies’ ongoing relationship with the signing of a new development and manufacturing agreement. Under terms of the new agreement, Recro will provide analytical validation services and cGMP manufacturing of regist...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters